Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 7, 2006. The report details a specific corporate action regarding share repurchases authorized by shareholders at the Annual General Meeting held on May 17, 2006.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share buyback transaction:
- Shares Purchased: 660,000 Ordinary shares of 25 pence each.
- Purchase Price: 1,513.3391 pence per share.
- Transaction Date: June 7, 2006.
Material Changes
Following the repurchase, the Company's share capital structure changed as follows:
- Treasury Shares: The Company now holds 170,201,678 shares in Treasury.
- Shares in Issue: There are 5,812,186,856 shares in issue (excluding Treasury shares).
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, outlook, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities in any jurisdiction.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (170,201,678) against subsequent filings.
- Confirm the total number of shares in issue (5,812,186,856) excluding Treasury shares.
- Review the Annual General Meeting minutes from May 17, 2006, to confirm the scope of the share repurchase authority.